Products

Analysis of biological big data in precision medicine and drug development (HEALTH by Next Deal, in Greek) October 3, 2022
eNIOS was awarded the 1st prize of Pfizer’s accelerator Start4Health September 7, 2022
Regulated IRE1α-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer (Nature Communications) May 20, 2022
Integration of Raman spectra with transcriptome data in glioblastoma multiforme defines tumour subtypes and predicts patient outcome November 16, 2021
Award to e-NIOS by the HDB – Hellenic Development Bank SA and Researcher’s Night September 24, 2021
Epigenetics in Breast Cancer Therapy-New Strategies and Future Nanomedicine Perspectives December 3, 2020

e-NIOS